Sovran Advisors LLC Sells 962 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Sovran Advisors LLC reduced its stake in HCA Healthcare, Inc. by 29.9% in the second quarter, holding 2,256 shares valued at $852,000 after selling 962 shares.
• HCA Healthcare reported a quarterly EPS of $6.84, surpassing analysts' expectations, and a revenue of $18.61 billion, which is a 6.4% increase compared to the previous year.
• The company declared a quarterly dividend of $0.72 per share, with a yield of 0.7%, to be paid on September 30th to shareholders on record as of September 16th.

Sovran Advisors LLC lessened its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 29.9% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,256 shares of the company's stock after selling 962 shares during the quarter. Sovran Advisors LLC's holdings in HCA Healthcare were worth $852,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Cheviot Value Management LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $26,000. Saudi Central Bank purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $26,000. WPG Advisers LLC purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $27,000. Atwood & Palmer Inc. purchased a new stake in shares of HCA Healthcare during the first quarter valued at approximately $28,000. Finally, Bartlett & CO. Wealth Management LLC grew its position in shares of HCA Healthcare by 888.9% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Up 0.2%

Shares of NYSE HCA traded up $1.00 during trading hours on Friday, hitting $402.06. The stock had a trading volume of 4,308,470 shares, compared to its average volume of 1,077,287. The company has a market capitalization of $94.08 billion, a P/E ratio of 16.90, a P/E/G ratio of 1.26 and a beta of 1.41. The firm's 50-day moving average price is $385.21 and its two-hundred day moving average price is $365.77. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the business posted $5.50 EPS. The business's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company's stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.30% of the company's stock.

Analyst Ratings Changes

HCA has been the subject of several analyst reports. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Cantor Fitzgerald restated an "overweight" rating and set a $444.00 price objective on shares of HCA Healthcare in a research note on Tuesday, August 26th. Wells Fargo & Company cut their price objective on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a research note on Thursday, August 14th. Finally, Bank of America boosted their price target on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research report on Wednesday, September 10th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat.com, HCA Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $407.75.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.